ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

KIDS vs BBNX // EV/EBITDA & P/E VALUATION

OrthoPediatrics Corp. (NASDAQ) VS. Beta Bionics Inc. (NASDAQ) • 15-METRIC TALLY: KIDS 7 — BBNX 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KIDS VS. BBNX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC KIDS BBNX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 73.10% 55.40% +17.70 KIDS /gross-margins <GO>
Return on Invested Capital (ROIC) -7.30% -22.10% +14.80 KIDS /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -1.94% -5.88% +3.94 KIDS /fcf-yield <GO>
Operating Margin -16.60% -60.00% +43.40 KIDS /operating-margins <GO>
Net Profit Margin -16.80% -60.00% +43.20 KIDS /net-margins <GO>
Revenue Growth (YoY) 15.40% 53.90% -38.50 BBNX /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.00 12.82 -9.82 BBNX /balance-sheet <GO>
Piotroski F-Score Quality 5/9 4/9 +1.00 KIDS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 74.7 42.4 +32.30 KIDS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $806.0M $910.6M -$104.6M BBNX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR KIDS REV BBNX REV KIDS GROSS % BBNX GROSS % KIDS FCF BBNX FCF
FY 2025 $236.3M $100.3M 73.1% 55.4% -$16.0M -$56.2M
FY 2024 $204.7M $65.1M 72.6% 55.1% -$41.3M -$51.7M
FY 2023 $148.7M $12.0M — — -$27.0M -$32.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KIDS // BETA —
BBNX // BETA —